Related Experiment Video
Updated: Nov 28, 2025
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
375
Current and Future Management of Locally Advanced and Metastatic Prostate Cancer.
1Medical Director, Carolina Urologic Research Center Myrtle Beach, SC.
Reviews in Urology
|November 26, 2020
Summary
Managing advanced prostate cancer (PCa) is complex. This review covers evolving treatment strategies, including surgery, radiation, chemotherapy, and androgen deprivation therapy (ADT), for individualized patient care.
Area of Science:
- Oncology
- Urology
Background:
- Prostate cancer (PCa) management is increasingly complex due to numerous treatment options.
- Locally advanced and metastatic PCa require nuanced, individualized treatment strategies.
Purpose of the Study:
- To review current and future approaches for managing locally advanced and metastatic prostate cancer.
- To discuss the evolving landscape of PCa treatment modalities.
Main Methods:
- Literature review of current and emerging therapies for prostate cancer.
- Analysis of treatment strategies combining surgery, radiation, chemotherapy, and androgen deprivation therapy (ADT).
Main Results:
- Treatment strategies are evolving with new approvals and pending agents for metastatic PCa.
- Individualized patient care considering clinical situations and preferences is crucial.
Conclusions:
- The management of advanced prostate cancer necessitates a comprehensive and personalized approach.
- Understanding evolving treatment options, including ADT and immunotherapy, is key for optimal patient outcomes.
Keywords:
Androgen deprivation therapyChemotherapyLocally advanced prostate cancerMetastatic prostate cancerProstate cancer
